Nuvilex has announced that its subsidiary, Medical Marijuana Sciences, plans to use the proprietary cellulose-based live-cell encapsulation technology known as Cell-in-a-Box to develop treatments for serious and deadly forms of cancer. ...
The FDA has approved R-Tech Ueno's novel ophthalmic solution, developed using Novozymes Biopharma's recombinant human albumin, to enter into Phase I/II trials. R-Tech is trialing RU-101 ophthalmic solution as a severe dry eye therapy. ...
The Israel's Ministry of Health (MOH) has granted approval to Medgenics to initiate two Phase I/II clinical trials of a subcutaneous autologous tissue implant, INFRADURE, in patients with hepatitis C. The objective of the trials is to ...
Tags: MOH, clinical trial, medical research
Janssen Biotech, a Johnson & Johnson company, has executed a license and development agreement for an investigational anti-cancer agent, daratumumab (HuMax-CD38), with Genmab. Daratumumab is a human CD38 monoclonal antibody which is ...
Tags: Daratumumab License, license and development agreement, anti-cancer